Full Text View
Tabular View
No Study Results Posted
Related Studies
Pegfilgrastim PBPC Mobilization Study
This study has been completed.
Study NCT00066092   Information provided by Amgen
First Received: August 4, 2003   Last Updated: February 20, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Hematology
Oncology
Additional conditions recognized in this trial
Hodgkin Disease
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
pegfilgrastim 12 mg
filgrastim
pegfilgrastim 6 mg
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services